Skip to main content Accessibility help
×
Home

Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers

  • Margaret Abraham (a1), Michael Seidenberg (a1), Dana A. Kelly (a1), Kristy A. Nielson (a2) (a3), John L. Woodard (a4), J. Carson Smith (a5), Sally Durgerian (a3) and Stephen M. Rao (a6)...

Abstract

Objective:

The Apolipoprotein (APOE) ε4 allele increases the risk for mild cognitive impairment (MCI) and dementia, but not all carriers develop MCI/dementia. The purpose of this exploratory study was to determine if early and subtle preclinical signs of cognitive dysfunction and medial temporal lobe atrophy are observed in cognitively intact ε4 carriers who subsequently develop MCI.

Methods:

Twenty-nine healthy, cognitively intact ε4 carriers (ε3/ε4 heterozygotes; ages 65–85) underwent neuropsychological testing and MRI-based measurements of medial temporal volumes over a 5-year follow-up interval; data were converted to z-scores based on a non-carrier group consisting of 17 ε3/ε3 homozygotes.

Results:

At follow-up, 11 ε4 carriers (38%) converted to a diagnosis of MCI. At study entry, the MCI converters had significantly lower scores on the Mini-Mental State Examination, Rey Auditory Verbal Learning Test (RAVLT) Trials 1–5, and RAVLT Immediate Recall compared to non-converters. MCI converters also had smaller MRI volumes in the left subiculum than non-converters. Follow-up logistic regressions revealed that left subiculum volumes and RAVLT Trials 1–5 scores were significant predictors of MCI conversion.

Conclusions:

Results from this exploratory study suggest that ε4 carriers who convert to MCI exhibit subtle cognitive and volumetric differences years prior to diagnosis.

Copyright

Corresponding author

*Correspondence and reprint requests to: Stephen M. Rao, PhD, Schey Center for Cognitive Neuroimaging, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue/U10, Cleveland, OH44195, USA, E-mail: raos2@ccf.org

References

Hide All
Baumgart, M., Snyder, H.M., Carrillo, M.C., Fazio, S., Kim, H., & Johns, H. (2015). Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dementia, 11(6), 718726. doi: 10.1016/j.jalz.2015.05.016
Carlesimo, G.A., Piras, F., Orfei, M.D., Iorio, M., Caltagirone, C., & Spalletta, G. (2015). Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer’s disease. Alzheimers Dementia (Amsterdam), 1(1), 2432. doi: 10.1016/j.dadm.2014.12.001
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., & Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), 921923. doi: 10.1126/science.8346443
Evans, T.E., Adams, H.H.H., Licher, S., Wolters, F.J., van der Lugt, A., Ikram, M.K., & Ikram, M.A. (2018). Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia. Neuroimage, 178, 129135. doi: 10.1016/j.neuroimage.2018.05.041
Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189198. doi: 10.1016/0022-3956(75)90026-6
Fouquet, M., Besson, F.L., Gonneaud, J., La Joie, R., & Chételat, G. (2014). Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan. Neuropsychology Review, 24(3), 290299. doi: 10.1007/s11065-014-9263-8
Haller, S., Montandon, M.L., Rodriguez, C., Ackermann, M., Herrmann, F.R., & Giannakopoulos, P. (2017). APOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline. American Journal of Neuroradiology, 38(7), 13351342. doi: 10.3174/ajnr.A5184
Hanseeuw, B.J., Van Leemput, K., Kavec, M., Grandin, C., Seron, X., & Ivanoiu, A. (2011). Mild cognitive impairment: differential atrophy in the hippocampal subfields. American Journal of Neuroradiology, 32(9), 16581661. doi: 10.3174/ajnr.A2589
Iglesias, J.E., Augustinack, J.C., Nguyen, K., Player, C.M., Player, A., Wright, M., Roy, N., Frosch, M.P., McKee, A.C., Wald, L.L., Fischl, B., Von Leemput, K., & The Alzheimer’s Disease Neuroimaging Initiative (2015). A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. Neuroimage, 115, 117137. doi: 10.1016/j.neuroimage.2015.04.042
Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., & Trojanowski, J.Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. The Lancet Neurology, 9(1), 119128. doi: 10.1016/s1474-4422(09)70299-6
Jurica, P.J., Leitten, C.L., & Mattis, S. (2001). DRS-2 Dementia Rating Scale-2: Professional Manual. Lutz, FL: Psychological Assessment Resources.
Lawton, M.P., & Brody, E.M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9(3), 179186.
O’Donoghue, M.C., Murphy, S.E., Zamboni, G., Nobre, A.C., & Mackay, C.E. (2018). APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: a review. Cortex, 104, 103123. doi: 10.1016/j.cortex.2018.03.025
Price, J.L., & Morris, J.C. (1999). Tangles and plaques in non-demented aging and “preclinical” Alzheimer’s disease. Annals of Neurology, 45, 358368. doi: 10.1002/1531-8249(199903)45:3<358:AID-ANA12>3.0.CO;2-X
Qian, J., Wolters, F.J., Beiser, A., Haan, M., Ikram, M.A., Karlawish, J., & Blacker, D. (2017). APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. PLoS Medicine, 14(3), e1002254. doi: 10.1371/journal.pmed.1002254
Rao, S.M., Bonner-Jackson, A., Nielson, K.A., Seidenberg, M., Smith, J.C., Woodard, J.L., & Durgerian, S. (2015). Genetic risk for Alzheimer’s disease alters the 5-year trajectory of semantic memory activation in cognitively intact elders. Neuroimage, 111, 136146.
Rey, A. (1958). L’examen clinique en psychologie. Paris: Presses Universitaires de France.
Schmidt, M. (1996). Rey Auditory And Verbal Learning Test: A Handbook. Los Angeles: Western Psychological Services.
Schmidt, K.S. (2004). Dementia Rating Scale-2 Alternate Form: Manual Supplement. Lutz, FL: Psychological Assessment Resources.
Seidenberg, M., Guidotti, L., Nielson, K.A., Woodard, J.L., Durgerian, S., Antuono, P., & Rao, S.M. (2009). Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology, 73(8), 612620. doi: 10.1212/WNL.0b013e3181b389ad
Stonnington, C.M., Chen, Y., Savage, C.R., Lee, W., Bauer, R.J. III, Sharieff, S., Thiyyagura, P., Alexander, G.E., Caselli, R.J., Locke, D.E.C., Reiman, E.M., & Chen, K. (2018). Predicting imminent progression to clinically significant memory decline using volumetric MRI and FDG PET. Journal of Alzheimer's Disease, 63(2), 603615. doi: 10.3233/JAD-170852
Sundermann, E.E., Maki, P., Biegon, A., Lipton, R.B., Mielke, M.M., Machulda, M., Bondi, M.W., & Alzheimer’s Disease Neuroimaging Initiative (2019). Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI. Neurology, 93(20), e1881e1889.
Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., & Leirer, V.O. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17(1), 3749. doi: 10.1016/0022-3956(82)90033-4

Keywords

Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers

  • Margaret Abraham (a1), Michael Seidenberg (a1), Dana A. Kelly (a1), Kristy A. Nielson (a2) (a3), John L. Woodard (a4), J. Carson Smith (a5), Sally Durgerian (a3) and Stephen M. Rao (a6)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.